Skip to main content

EN
ÍS

Forsíða

Forsíða

Sigurður Ingvarsson - Prófessor

Sigurður Ingvarsson

–

Heilbrigðisvísindasvið

Sigurður Ingvarsson

Prófessor

Prófessor, forstöðumaður á Keldum

Aðsetur
Tilraunastöð HÍ. í meinafræði - Keldum
Sími
8943235, 5855123 8943235
Tölvupóstur
siguring [hjá] hi.is

Starfseining
Læknadeild
Vefsíða
http://www.keldur.is

ORCID vefsíða
https://orcid.org/0000-0003-4125-1714
Rannsóknagátt – Sigurður Ingvarsson

Útgefið efni

2014

UntitiledIcelandic Agricultural Sciences
THE GENETIC LANDSCAPE OF FAMILIAL BREAST CANCER IN ICELANDAnticancer Research
MicroRNA-451 suppresses tumor cell growth by down-regulating IL6R gene expressionCancer Epidemiology
The IL6R Expression is Downregulated by miR-451 in Tumour ProgressionScandinavian Journal of Immunology

2013

In memoriam Bjorn Sigurdsson born 100 years agoIcelandic Agricultural Sciences
EditorialIcelandic Agricultural Sciences

2012

Demethylation of the region around exon 2 of MLH1 gene in gastrointestinal cancerAnticancer Research
Demethylation of the region around exon 2 of MLH1 gene in gastrointestinal cancer.
The LIMD1 protein bridges an association between the prolyl hydroxylases and VHL to repress HIF-1 activityNature Cell Biology
Demethylation of the Region around Exon 2 of MLH1 Gene in Gastrointestinal CancerAnticancer Research

2011

Spreading of alu methylation to the promoter of the mlh1 gene in gastrointestinal cancerPLoS ONE
Spreading of Alu Methylation to the Promoter of the MLH1 Gene in Gastrointestinal CancerPlos One
Anders Jahre-verolauninLaeknabladid
Quantitative analysis of miRNa expression in seven human foetal and adult organsPLoS ONE
Quantitative Analysis of miRNA Expression in Seven Human Foetal and Adult OrgansPlos One

2010

Quantitative analysis of miRNA expression in several developmental stages of human liversHepatology Research
The MLH1-93 promoter variant influences gene expressionCancer Epidemiology

2009

Identification of miRNAs in a Liver of a Human Fetus by a Modified MethodPlos One
Identification of miRNAs in a liver of a human fetus by a modified methodPLoS ONE
The sixty year anniversary of the Institute for Experimental Pathology, University of Iceland at Keldur PrefaceIcelandic Agricultural Sciences

2008

CELLULAR BIOLOGY OF BREAST CANCER, FOCUSING ON GENOMIC AND CLINICOPATHOLOGICAL EVENTS IN CARRIERS OF A BRCA2 FOUNDER MUTATIONAnticancer Research
In vitro analysis of expression vectors for DNA vaccination of horses: The effect of a Kozak sequenceActa Veterinaria Scandinavica
In vitro analysis of expression vectors for DNA vaccination of horses: the effect of a Kozak sequenceActa Veterinaria Scandinavica

2007

Duplicated sequence motif in the long terminal repeat of maedi-visna virus extends cell tropism and is associated with neurovirulenceJournal of Virology
Duplicated sequence motif in the long terminal repeat of maedi-visna viras extends cell tropism and is associated with neurovirulenceJournal of Virology

2006

Genomic instability and breast cancer progressionCancer Genomics and Proteomics

2005

Loss of RALT/MIG-6 expression in ERBB2-amplified breast carcinomas enhances ErbB-2 oncogenic potency and favors resistance to HerceptinOncogene
Deletions at the chromosome 3 common eliminated region 1 on 3p21.3 in human breast tumors.
Tumor suppressor genes on human chromosome 3 and cancer pathogenesisCancer Genomics and Proteomics
[Uniparental disomy of chromosome 11 in a patient with Beckwith-Wiedemann syndrome. First reported case in Iceland].
Uniparental disomy of chromosome 11 in a patient with Beckwith-Wiedemann syndrome. First reported case in Iceland | Tvístaeoa litnings nr. 11 frá föour hjá sjúklingi meo Beckwith-Wiedemann heilkenni. Fyrsta greining á Islandi--Sjúkratilfelli.Læknabladid
Deletions at the chromosome 3 common eliminated region 1 on 3p21.3 in human breast tumorsBreast Cancer Research

2004

Interstitial deletions including chromosome 3 common eliminated region I (C3CERI) prevail in human solid tumors from 10 different tissuesGenes Chromosomes & Cancer
ALTERATIONS AT CHROMOSOME 3 AND CANCER PATHOGENESISAnticancer Research
Genetics of breast cancerDrugs of Today
Genetics of breast cancer.

2003

Germline mutations in DNA repair and cell cycle checkpoint genes: consequential somatic gene alterations and genome instability.

2002

Loss of heterozygosity at the FHIT gene in different solid human tumours and its association with survival in colorectal cancer patientsAnticancer Research
Loss of heterozygosity at the FHIT gene in different solid human tumours and its association with survival in colorectal cancer patientsAnticancer Research
Pattern of FHIT LOH in different solid human tumors; association with survival in colorectal cancer patientsCancer Epidemiology Biomarkers & Prevention
High frequency of LOH, MSI and abnormal expression of FHIT in gastric cancerEuropean Journal of Cancer
High frequency of LOH, MSI and abnormal expression of FHIT in gastric cancerEuropean Journal of Cancer
Mutation analysis of the CHK2 gene in breast carcinoma and other cancersBreast Cancer Research
Loss of heterozygosity at the FHIT gene in different solid human tumours and its association with survival in colorectal cancer patients.
Mutation analysis of the CHK2 gene in breast carcinoma and other cancersBreast Cancer Research

2001

Similar regions of human chromosome 3 are eliminated from or retained in human/human and human/mouse microcell hybrids during tumor growth in severe combined immunodeficient (SCID) miceProceedings of the National Academy of Sciences of the United States of America
FHIT alterations in breast cancerSeminars in Cancer Biology
Alterations of the FHIT gene in breast cancer: association with tumor progression and patient survival.Cancer Detection and Prevention
Alterations of E-cadherin and beta-catenin in gastric cancer.BMC cancer [electronic resource]
Alterations of E-cadherin and beta-catenin in gastric cancerBmc Cancer
Breast cancer: introductionSeminars in Cancer Biology
Alterations of the FHIT gene in breast cancer: Association with tumor progression and patient survivalCancer Detection and Prevention
Alterations of the FHIT gene in breast cancer: association with tumor progression and patient survival.

2000

Population studies and validation of paternity determinations by six microsatellite lociJournal of Forensic Sciences
The effect of mismatch repair deficiency on tumourigenesis; microsatellite instability affecting genes containing short repeated sequences.International journal of oncology
Analysis of the fragile histidine triad (FHIT) gene in lobular breast cancerEuropean Journal of Cancer
Population studies and validation of paternity determinations by six microsatellite loci.
Altered expression of E-cadherin in breast cancerpatterns, mechanisms and clinical significanceEuropean Journal of Cancer
The effect of mismatch repair deficiency on tumourigenesis; microsatellite instability affecting genes containing short repeated sequencesInternational Journal of Oncology
Population studies and validation of paternity determinations by six microsatellite lociJournal of Forensic Sciences
Molecular biology of breast cancer.
Analysis of the fragile histidine triad (FHIT) gene in lobular breast cancerEuropean Journal of Cancer
Analysis of chromosome alterations and the E-cadherin and FHIT genes in lobular breast cancer.
The effect of mismatch repair deficiency on tumourigenesis; microsatellite instability affecting genes containing short repeated sequences.
Altered expression of E-cadherin in breast cancer: patterns, mechanisms and clinical significanceEuropean Journal of Cancer
Molecular biology of breast cancer.Oncology reports
Chromosome 8p alterations in sporadic and BRCA2 999de15 linked breast cancerJournal of Medical Genetics
Chromosome 8p alterations in sporadic and BRCA2 999del5 linked breast cancerJournal of Medical Genetics

1999

Replication error in human breast cancer: Comparison with clinical variables and family history of cancerOncology Reports
Chromosome alterations and E-cadherin gene mutations in human lobular breast cancerBritish Journal of Cancer
The Brca1 and Brca2 proteins and tumor pathogenesisAnticancer Research
Molecular genetics of breast cancer progressionSeminars in Cancer Biology
Reduced Fhit expression in sporadic and BRCA2-linked breast carcinomasCancer Research
Replication error in colorectal carcinoma: Association with loss of heterozygosity at mismatch repair loci and clinicopathological variablesAnticancer Research
Replication error in human breast cancer: Comparison with clinical variables and family history of cancerOncology Reports
Reduced Fhit expression in sporadic and BRCA2-linked breast carcinomas.
Altered expression of E-cadherin in breast cancer: Patterns, mechanisms and clinical significanceEuropean Journal of Cancer
Loss of heterozygosity at chromosome 1p in different solid human tumours: association with survivalBritish Journal of Cancer
Somatic alterations of chromosome 8p in sporadic and BRCA2 999del5 linked breast cancerAmerican Journal of Human Genetics
Replication error in human breast cancer: comparison with clinical variables and family history of cancer.
The Brca1 and Brca2 proteins and tumor pathogenesis.
Replication error in colorectal carcinoma: association with loss of heterozygosity at mismatch repair loci and clinicopathological variables.
The Brca1 and Brca2 proteins and tumor pathogenesisAnticancer Research
Reduced Fhit expression in sporadic and BRCA2-linked breast carcinomasCancer Research
Chromosome alterations and E-cadherin gene mutations in human lobular breast cancerBritish Journal of Cancer
Replication error in colorectal carcinoma: Association with loss of heterozygosity at mismatch repair loci and clinicopathological variablesAnticancer Research
Loss of heterozygosity at chromosome 1p in different solid human tumours: Association with survivalBritish Journal of Cancer

1998

High frequency of LOH at chromosome 18q in human breast cancer: Association with high S-phase fraction and low progesterone receptor contentAnticancer Research
Mapping lass of heterozygosity at chromosome 13q: Loss at 13q12-q13 is associated with breast tumour progression and poor prognosisEuropean Journal of Cancer
Identification of a novel splice-site mutation of the BRCA1 gene in two breast cancer families: screening reveals low frequency in Icelandic breast cancer patients.
High incidence of loss of heterozygosity in breast tumors from carriers of the BRCA2 999del5 mutation.
High incidence of loss of heterozygosity at chromosome 17p13 in breast tumours from BRCA2 mutation carriersOncogene
High incidence of loss of heterozygosity in breast tumors from carriers of the BRCA2 999del5 mutationCancer Research
Mapping loss of heterozygosity at chromosome 13q: Loss at 13q12-q13 is associated with breast turnout progression and poor prognosisEuropean Journal of Cancer
Identification of a novel splicesite mutation of the BRCAL gene in two breast cancer families: Screening reveals low frequency in icelandic breast cancer patientsHuman Mutation
High frequency of LOH at chromosome 18q in human breast cancer: Association with high S-phase fraction and low progesterone receptor contentAnticancer Research
High incidence of loss of heterozygosity in breast tumors from carriers of the BRCA2 999del5 mutationCancer Research
Identification of a novel splice-site mutation of the BRCA1 gene in two breast cancer families: Screening reveals low frequency in Icelandic breast cancer patientsHuman Mutation
Chromosome imbalance at the 3p14 region in human breast tumours: High frequency in patients with inherited predisposition due to BRCA2European Journal of Cancer
High frequency of LOH at chromosome 18q in human breast cancer: association with high S-phase fraction and low progesterone receptor content.
High incidence of loss of heterozygosity at chromosome 17p13 in breast tumours from BRCA2 mutation carriersOncogene
Chromosome imbalance at the 3p14 region in human breast tumours: High frequency in patients with inherited predisposition due to BRCA2European Journal of Cancer

1997

Loss of heterozygosity at chromosome 7q in human breast cancer: Association with clinical variablesAnticancer Research
Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutationsCancer Research
Loss of heterozygosity at chromosome 7q in human breast cancer: Association with clinical variablesAnticancer Research
Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations.
Loss of heterozygosity at chromosome 7q in human breast cancer: association with clinical variables.
Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutationsCancer Research

1996

Deletion mapping of chromosome 16 in human breast cancer; Putative location of tumor suppressor gene(s)Cytogenetics and Cell Genetics
Frequent occurrence of BRCA2 linkage in Icelandic breast cancer families and segregation of a common BRCA2 haplotypeAmerican Journal of Human Genetics
Loss of heterozygosity at chromosome 1p in human breast cancer.
Loss of heterozygosity at chromosome 1p in human breast cancer: Association with high S-phase, reduced patient survival and deletions at other chromosome regionsInternational Journal of Oncology
High prevalence of the 999del5 mutation in Icelandic breast and ovarian cancer patientsCancer Research
Loss of heterozygosity on chromosome arm 3p in nasopharyngeal carcinomaGenes Chromosomes & Cancer
Frequent occurrence of BRCA2 linkage in Icelandic breast cancer families and segregation of a common BRCA2 haplotype.
Loss of heterozygosity at chromosome 1p in human breast cancer: Association with high S-phase, reduced patient survival and deletions at other chromosome regionsInternational Journal of Oncology
Report of the fourth international workshop on human chromosome 16 mapping 1995 - Held on 12-14 November 1995 at the University of Leiden, The NetherlandsCytogenetics and Cell Genetics
High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patientsCancer Research
High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patients.
Loss of heterozygosity on chromosome arm 3p in nasopharyngeal carcinomaGenes Chromosomes and Cancer
Frequent occurrence of BRCA2 linkage in Icelandic breast cancer families and segregation of a common BRCA2 haplotypeAmerican Journal of Human Genetics

1995

Mapping of chromosome 3 alterations in human breast cancer using microsatellite PCR markers: Correlation with clinical variablesInternational Journal of Oncology
LOSS OF HETEROZYGOSITY AT CHROMOSOME-11 IN BREAST-CANCER - ASSOCIATION OF PROGNOSTIC FACTORS WITH GENETIC ALTERATIONSBritish Journal of Cancer
Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12-q13.
Loss of heterozygosity at chromosome 6q correlates with tumor progression and patient survival.
Different Tumor Types from BRCA2 Carriers Show Wild-Type Chromosome Deletions on 13q12-q13Cancer Research
Mapping of chromosome-3 alterations in human breast-cancer using microsatellite PCR markers - correlation with clinical-variables.
LINKAGE ANALYSIS AND ALLELIC IMBALANCE IN HUMAN BREAST-CANCER KINDREDS USING MICROSATELLITE MARKERS FROM THE SHORT ARM OF CHROMOSOME-3Human Genetics
Identification of a breast tumor with microsatellite instability in a potential carrier of the hereditary non-polyposis colon cancer trait.
Loss of heterozygosity on chromosome 9 in human breast cancer: Association with clinical variables and genetic changes at other chromosome regionsInternational Journal of Cancer
MAPPING OF CHROMOSOME-3 ALTERATIONS IN HUMAN BREAST-CANCER USING MICROSATELLITE PCR MARKERS - CORRELATION WITH CLINICAL-VARIABLESInternational Journal of Oncology
Loss of heterozygosity at chromosome 6q correlates with tumor progression and patient survivalInternational Journal of Oncology
Linkage analysis and allelic imbalance in human breast cancer kindreds using microsatellite markers from the short arm of chromosome 3Human Genetics
IDENTIFICATION OF A BREAST-TUMOR WITH MICROSATELLITE INSTABILITY IN A POTENTIAL CARRIER OF THE HEREDITARY NONPOLYPOSIS COLON-CANCER TRAITClinical Genetics
Identification of a breast tumor with microsatellite instability in a potential carrier of the hereditary non‐polyposis colon cancer traitClinical Genetics
HIGH-FREQUENCY OF ALLELIC IMBALANCE AT CHROMOSOME REGION 16Q22-23 IN HUMAN BREAST-CANCER - CORRELATION WITH HIGH PGR AND LOW S-PHASEInternational Journal of Cancer
DIFFERENT TUMOR TYPES FROM BRCA2 CARRIERS SHOW WILD-TYPE CHROMOSOME DELETIONS ON 13Q12Q13Cancer Research
LOSS OF HETEROZYGOSITY AT CHROMOSOME 6Q CORRELATES WITH TUMOR PROGRESSION AND PATIENT SURVIVALInternational Journal of Oncology

1994

THE V-ERBA ONCOPROTEIN OF THE AEV TRANSFORMING RETROVIRUS BINDS TO THE PROMOTER REGION OF THE ERYTHROID-SPECIFIC BAND-3 GENESlow Infections of the Central Nervous System: the Legacy of Dr Bjorn Sigurdsson

1993

URINARY SYSTEM TUMORS IN A FAMILYEuropean Journal of Cancer

1991

Chromosomal assignment of retinoic acid receptor (RAR) genes in the human, mouse, and rat genomesGenomics
CHROMOSOMAL ASSIGNMENT OF 5 CANCER-ASSOCIATED RAT GENES - 2 THYROID-HORMONE RECEPTOR (ERBA) GENES, 2 ERBB GENES AND THE RETINOBLASTOMA GENEOncogene
Chromosomal assignment of five cancer-associated rat genes: two thyroid hormone receptor (ERBA) genes, two ERBB genes and the retinoblastoma gene.
THE MOST FREQUENTLY LOST ALLELIC SITE IN HUMAN RENAL-CELL CARCINOMA (D3F15S2) ON THE SHORT ARM OF CHROMOSOME-3 HAS HOMOLOGOUS SEQUENCES ON RAT CHROMOSOME-8Cytogenetics and Cell Genetics
CHROMOSOMAL ASSIGNMENT OF RETINOIC ACID RECEPTOR (RAR) GENES IN THE HUMAN, MOUSE, AND RAT GENOMESGenomics
Chromosomal assignment of five cancer-associated rat genes: Two thyroid hormone receptor (ERBA) genes, two ERBB genes and the retinoblastoma geneOncogene
The most frequently lost allelic site in human renal cell carcinoma (D3F15S2) on the short arm of chromosome 3 has homologous sequences on rat chromosome 8.

1990

Recombinant plasmid expressing the entire coding region of the Bmyc putative protein.
A gene near the D3F15S2 site on 3p is expressed in normal human kidney but not or only at a severely reduced level in 11 of 15 primary renal cell carcinomas (RCC)Oncogene
The myc gene family proteins and their role in transformation and differentiationSeminars in Cancer Biology
A GENE NEAR THE D3F15S2 SITE ON 3P IS EXPRESSED IN NORMAL HUMAN KIDNEY BUT NOT OR ONLY AT A SEVERELY REDUCED LEVEL IN 11 OF 15 PRIMARY RENAL-CELL CARCINOMAS (RCC)Oncogene
A gene near the D3F15S2 site on 3p is expressed in normal human kidney but not or only at a severely reduced level in 11 of 15 primary renal cell carcinomas (RCC).
DIFFERENCES IN C-MYC AND PVT-1 AMPLIFICATION IN SEWA SARCOMA SUBLINES SELECTED FOR ADHERENT OR NONADHERENT GROWTHInternational Journal of Cancer
RECOMBINANT PLASMID EXPRESSING THE ENTIRE CODING REGION OF THE BMYC PUTATIVE PROTEINJournal of Clinical & Laboratory Immunology
Recombinant plasmid expressing the entire coding region of the Bmyc putative protein.Journal of Clinical and Laboratory Immunology
The myc gene family proteins and their role in transformation and differentiation.

1989

Nucleotide sequence of the rat Bmyc geneOncogene
Nucleotide sequence of the rat Bmyc gene.
NUCLEOTIDE-SEQUENCE OF THE RAT BMYC GENEOncogene

1988

Structure and expression of B-myc, a new member of the myc gene family.
Drosophila homolog of the murine Int-1 protooncogeneProceedings of the National Academy of Sciences of the United States of America
AMPLIFICATION OF C-MYC AND PVT-1 HOMOLOGOUS SEQUENCES IN ACUTE NONLYMPHATIC LEUKEMIALeukemia Research
CHROMOSOME LOCALIZATION AND EXPRESSION PATTERN OF LMYC AND BMYC IN MURINE EMBRYONAL CARCINOMA-CELLSOncogene
Chromosome localization and expression pattern of Lmyc and Bmyc in murine embryonal carcinoma cellsOncogene
Chromosome localization and expression pattern of Lmyc and Bmyc in murine embryonal carcinoma cells.
ELEVATED EXPRESSION OF C-MYC AND N-MYC PRODUCES DISTINCT CHANGES IN NUCLEAR FINE-STRUCTURE AND CHROMATIN ORGANIZATIONOncogene
Consistent chromosome 3p deletion and loss of heterozygosity in renal cell carcinomaProceedings of the National Academy of Sciences of the United States of America
STRUCTURE AND EXPRESSION OF B-MYC, A NEW MEMBER OF THE MYC GENE FAMILYMolecular and Cellular Biology
Elevated expression of c-myc and N-myc produces distinct changes in nuclear fine structure and chromatin organizationOncogene
Rat c-raf oncogene is located on chromosome 4 and may be activated by sequences from chromosome 13Somatic Cell and Molecular Genetics
Elevated expression of c-myc and N-myc produces distinct changes in nuclear fine structure and chromatin organization.
CONSISTENT CHROMOSOME-3P DELETION AND LOSS OF HETEROZYGOSITY IN RENAL-CELL CARCINOMAProceedings of the National Academy of Sciences of the United States of America
DROSOPHILA HOMOLOG OF THE MURINE INT-1 PROTOONCOGENEProceedings of the National Academy of Sciences of the United States of America
RAT C-RAF ONCOGENE IS LOCATED ON CHROMOSOME-4 AND MAY BE ACTIVATED BY SEQUENCES FROM CHROMOSOME-13Somatic Cell and Molecular Genetics
Structure and expression of B-myc, a new member of the myc gene familyMolecular and Cellular Biology

1987

MAPPING OF LMYC AND NMYC TO RAT CHROMOSOME-5 AND CHROMOSOME-6Somatic Cell and Molecular Genetics
Mapping of Lmyc and Nmyc to rat chromosomes 5 and 6Somatic Cell and Molecular Genetics
SIMILARITIES AND DIFFERENCES IN THE REGULATION OF N-MYC AND C-MYC GENES IN MURINE EMBRYONAL CARCINOMA-CELLSExperimental Cell Research
THE RAT MIS1/PVT-1 LOCUS IS SYNTENIC WITH MYC ON CHROMOSOME-7Cytogenetics and Cell Genetics
Specific polypeptide differences in normal versus malignant human breast tissues by two-dimensional electrophoresisBreast Cancer Research and Treatment
SPECIFIC POLYPEPTIDE DIFFERENCES IN NORMAL VERSUS MALIGNANT HUMAN-BREAST TISSUES BY TWO-DIMENSIONAL ELECTROPHORESISBreast Cancer Research and Treatment
The rat MIS1/Pvt-1 locus is syntenic with MYC on chromosome 7.

1986

MULTIPLE CHROMOSOMAL REARRANGEMENTS IN A SPONTANEOUSLY ARISING T(6-7) RAT IMMUNOCYTOMA JUXTAPOSE C-MYC AND IMMUNOGLOBULIN HEAVY-CHAIN SEQUENCESProceedings of the National Academy of Sciences of the United States of America
Catabolite repressive effects of 5-thio-D-glucose on Saccharomyces cerevisiae.
c-myc activation in spontaneous rat immunocytomas containing a 6;7 chromosomal translocation.
CATABOLITE REPRESSIVE EFFECTS OF 5-THIO-D-GLUCOSE ON SACCHAROMYCES-CEREVISIAEJournal of General Microbiology
Catabolite repressive effects of 5-thio-D-glucose on Saccharomyces cerevisiae.Journal of General Microbiology
Multiple chromosomal rearrangements in a spontaneously arising t(6;7) rat immunocytoma juxtapose c-myc and immunoglobulin heavy chain sequencesProceedings of the National Academy of Sciences of the United States of America
c-myc activation in spontaneous rat immunocytomas containing a 6;7 chromosomal translocation.Current Topics in Microbiology and Immunology
C-MYC ACTIVATION IN SPONTANEOUS RAT IMMUNOCYTOMAS CONTAINING A 6-7 CHROMOSOMAL TRANSLOCATIONCurrent Topics in Microbiology and Immunology

1985

CLONING AND CHARACTERIZATION OF THE DNA-SEQUENCE TRANSPOSED TO THE ONCOGENE C-MYC IN RAT IMMUNOCYTOMAS WITH T(6-7) CHROMOSOMAL TRANSLOCATIONScandinavian Journal of Immunology
GENE LOCALIZATION ON SORTED CHROMOSOMES - DEFINITIVE EVIDENCE ON THE RELATIVE POSITIONING OF GENES PARTICIPATING IN THE MOUSE PLASMACYTOMA-ASSOCIATED TYPICAL TRANSLOCATIONProceedings of the National Academy of Sciences of the United States of America

1984

ISOENZYME PATTERN AND SUBCELLULAR-LOCALIZATION OF HEXOKINASES IN HUMAN-BREAST CANCER AND NONPATHOLOGICAL BREAST-TISSUEInternational Journal of Cancer

Sérsvið:

Frumulíffræði

Sameindalíffræði